Phillip G. Febbo, Chief Scientific & Med Officer at Veracyte, sold VCYT on Sep 4, 2026
Data as of Oct 16
▼ SELL$446K10,405 shares at $42.89Phillip G. Febbo Chief Scientific & Med OfficerVCYT Veracyte, Inc.
- Traded
- Sep 4, 2026
- Disclosed
- Sep 4, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
VCYT since disclosure
+1.4%
after the sale
Similar stocks (XLV) since disclosure
+3.1%
XLV — its sector index fund
Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLPhillip G. Febbo Chief Scientific & Med OfficerVCYT Veracyte, Inc.$118Kdisclosed Sep 4 · filed the same day